Hematology/Oncology

Top Story

Deferred therapy may benefit some patients with mantle cell lymphoma

Deferred therapy may benefit some patients with mantle cell lymphoma
May 26, 2016

Deferring initial treatment for more than 90 days prolonged OS among certain patients with mantle cell lymphoma, according to a national cohort analysis.

Patients most likely to benefit from deferred treatment included those who were male, younger and had no comorbidities.

In the Journals

Emicizumab reduces bleeding in patients with severe hemophilia A

May 25, 2016
Weekly subcutaneous administration of the bispecific antibody emicizumab decreased the rate of bleeding events in patients with hemophilia A, according to the results of…
In the Journals

Male cancer survivors less likely to have children

May 25, 2016
Male survivors of childhood cancer diagnosed before age 25 years appeared less likely to have children and more likely to require assisted reproduction than men who did…
In the Journals

Adults with previous nonmelanoma skin cancer more likely to use sun protection, but still sunburn

May 25, 2016
While adults with previous nonmelanoma skin cancer were more likely to practice sun protection compared with people without a history of skin cancer, they reported…
In the Journals

Women with new-onset AF at elevated risk for cancer

May 25, 2016
In a cohort of healthy women at baseline, those who developed atrial fibrillation had elevated risk for cancer after their atrial fibrillation diagnosis, according to…
More News Headlines »
CME Video

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Video
Meeting News Coverage

VIDEO: Some women with early-stage breast cancer can safely avoid adjuvant chemotherapy

May 4, 2016
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan